Skip to content

Lifecore Biomedical, Inc. LFCR Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Baxter International logo
Baxter InternationalBAX
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
ADMA Biologics logo
ADMA BiologicsADMA
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s common stock, shares issued (in shares)?
Lifecore Biomedical, Inc. (LFCR) reported common stock, shares issued (in shares) of $37.48M in Q1 2026.
What is the long-term trend for Lifecore Biomedical, Inc.'s common stock, shares issued (in shares)?
Over 2 years (2023 to 2026), Lifecore Biomedical, Inc.'s common stock, shares issued (in shares) has grown at a 11.2% compound annual growth rate (CAGR), from $30.32M to $37.48M.